Overview

ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment

Status:
Not yet recruiting
Trial end date:
2025-06-30
Target enrollment:
0
Participant gender:
Female
Summary
The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine boluses for treating postspinal anesthesia hypotension under intensive treatment during cesarean section
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
General Hospital of Ningxia Medical University
Treatments:
Norepinephrine
Oxymetazoline
Phenylephrine
Vasoconstrictor Agents
Criteria
Inclusion Criteria:

- 18-45 years

- Primipara or multipara

- Singleton pregnancy ≥37 weeks

- American Society of Anesthesiologists physical status classification I to II

- Scheduled for cesarean section under spinal anesthesia

Exclusion Criteria:

- Body height < 150 cm

- Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2

- Eclampsia or chronic hypertension or baseline blood pressure ≥180 mmHg

- Hemoglobin < 7g/dl

- Fetal distress, or known fetal developmental anomaly